Generic placeholder image

Infectious Disorders - Drug Targets

Author(s): Amal A. Mohamed, Nouran Mohamed, Seham Mohamoud, Fawkia E. Zahran, Rania Abdelmonem Khattab, Dalia Ali El-Damasy, Eman Alsayed and Sherief Abd-Elsalam*

DOI: 10.2174/1871526520666200520112848

DownloadDownload PDF Flyer Cite As
SARS-CoV-2: The Path of Prevention and Control

Page: [358 - 362] Pages: 5

  • * (Excluding Mailing and Handling)

Abstract

The 2019 coronavirus pandemic (COVID-19) continues to expand worldwide. Although the number of cases and the death rate among children and adolescents are reported to be low compared to adults, limited data have been reported. We urgently need to find the treatment and vaccine to stop the epidemic. Vaccine development is in progress, but any approved and effective vaccine for COVID-19 will take at least 12 to 18 months. The World Health Organization (WHO), the Center for Disease Control and Prevention (CDC), and the Food and Agriculture Organization (FAO) have issued instructions and strategies for controlling COVID-19 outbreak to the general public, physicians, travelers and injured patients to follow so that the transmission to a healthy population can be prevented. In this review, we summarize demographic data, clinical characteristics, complications and outcomes and finally prevention and control strategies for this serious pandemic.

Keywords: Coronavirus, viruses, SARS, pandemic, vaccine, epidemic.

[1]
WHO. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV), 2020, Available from: https://www.who.int/news-room/detail/30–01–2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)
[2]
Rivers, C.; Chretien, J-P.; Riley, S.; Pavlin, J.A.; Woodward, A.; Brett-Major, D.; Maljkovic Berry, I.; Morton, L.; Jarman, R.G.; Biggerstaff, M.; Johansson, M.A.; Reich, N.G.; Meyer, D.; Snyder, M.R.; Pollett, S. Using “outbreak science” to strengthen the use of models during epidemics. Nat. Commun., 2019, 10(1), 3102.
[http://dx.doi.org/10.1038/s41467-019-11067-2] [PMID: 31308372]
[3]
Morgan, O. How decision makers can use quantitative approaches to guide outbreak responses. Philos Trans R Soc Lond B Biol Sci. , 2019, 374(1776), 20180365.
[http://dx.doi.org/10.1098/rstb.2018.0365]
[4]
Xu, B.; Kraemer, M.U.G.; Xu, B.; Gutierrez, B.; Mekaru, S.; Sewalk, K.; Kraemer, M. Open COVID-19 Data Curation Group. Open access epidemiological data from the COVID-19 outbreak. Lancet Infect Dis, 2020, 3099(20), 30119-5.
[http://dx.doi.org/10.1016/S1473-3099(20)30119-5] [PMID: 32087115]
[5]
Sun, K.; Chen, J.; Viboud, C. Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Lancet Digit Health, 2020, 2(4), e201-e208.
[http://dx.doi.org/10.1016/S2589-7500(20)30026-1] [PMID: 32309796]
[6]
Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; Cheng, Z.; Yu, T.; Xia, J.; Wei, Y.; Wu, W.; Xie, X.; Yin, W.; Li, H.; Liu, M.; Xiao, Y.; Gao, H.; Guo, L.; Xie, J.; Wang, G.; Jiang, R.; Gao, Z.; Jin, Q.; Wang, J.; Cao, B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223), 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[7]
Lake, M.A. What we know so far: COVID-19 current clinical knowledge and research. Clin. Med. (Lond.), 2020, 20(2), 124-127.
[http://dx.doi.org/10.7861/clinmed.2019-coron] [PMID: 32139372]
[8]
Chen, N.; Zhou, M.; Dong, X.; Qu, J.; Gong, F.; Han, Y.; Qiu, Y.; Wang, J.; Liu, Y.; Wei, Y.; Xia, J.; Yu, T.; Zhang, X.; Zhang, L. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223), 507-513.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[9]
Chan, J.F-W.; Yuan, S.; Kok, K-H.; To, K.K.; Chu, H.; Yang, J.; Xing, F.; Liu, J.; Yip, C.C.; Poon, R.W.; Tsoi, H.W.; Lo, S.K.; Chan, K.H.; Poon, V.K.; Chan, W.M.; Ip, J.D.; Cai, J.P.; Cheng, V.C.; Chen, H.; Hui, C.K.; Yuen, K.Y. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet, 2020, 395(10223), 514-523.
[http://dx.doi.org/10.1016/S0140-6736(20)30154-9] [PMID: 31986261]
[10]
Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; Xing, X.; Xiang, N.; Wu, Y.; Li, C.; Chen, Q.; Li, D.; Liu, T.; Zhao, J.; Liu, M.; Tu, W.; Chen, C.; Jin, L.; Yang, R.; Wang, Q.; Zhou, S.; Wang, R.; Liu, H.; Luo, Y.; Liu, Y.; Shao, G.; Li, H.; Tao, Z.; Yang, Y.; Deng, Z.; Liu, B.; Ma, Z.; Zhang, Y.; Shi, G.; Lam, T.T.Y.; Wu, J.T.; Gao, G.F.; Cowling, B.J.; Yang, B.; Leung, G.M.; Feng, Z.; Cowling, B.J.; Yang, B.; Leung, G. M and Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia. N. Engl. J. Med., 2020, 382(13), 1199-1207.
[http://dx.doi.org/10.1056/NEJMoa2001316] [PMID: 31995857]
[11]
Wu, F.; Zhao, S.; Yu, B.; Chen, Y-M.; Wang, W.; Song, Z-G.; Hu, Y.; Tao, Z-W.; Tian, J-H.; Pei, Y-Y.; Yuan, M-L.; Zhang, Y-L.; Dai, F-H.; Liu, Y.; Wang, Q-M.; Zheng, J-J.; Xu, L.; Holmes, E.C.; Zhang, Y.Z. A new coronavirus associated with human respiratory disease in China. Nature, 2020, 579(7798), 265-269.
[http://dx.doi.org/10.1038/s41586-020-2008-3] [PMID: 32015508]
[12]
Zhou, P.; Yang, X.L.; Wang, X.G.; Hu, B.; Zhang, L.; Zhang, W.; Si, H.R.; Zhu, Y.; Li, B.; Huang, C.L.; Chen, H.D.; Chen, J.; Luo, Y.; Guo, H.; Jiang, R.D.; Liu, M.Q.; Chen, Y.; Shen, X.R.; Wang, X.; Zheng, X.S.; Zhao, K.; Chen, Q.J.; Deng, F.; Liu, L.L.; Yan, B.; Zhan, F.X.; Wang, Y.Y.; Xiao, G.F.; Shi, Z.L. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 2020, 579(7798), 270-273.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]
[13]
Gorbalenya, A.E.; Baker, S.C.; Baric, R.S.; Groot, R.J.D.; Drosten, C.; Gulyaeva, A.A.; Haagmans, B.L.; Lauber, C.; Leontovich, A.M.; Neuman, B.W.; Penzar, D.; Perlman, S.; Poon, L.L.M.; Samborskiy, D.; Sidorov, I.A.; Sola, I.; Ziebuhr, J. Severe acute respiratory syndrome-related coronavirus: The species and its viruses—a statement of the Coronavirus Study Group. Preprint at https://www.biorxiv.org/content/10.1101/2020.02.07.937862v1 2020
[14]
Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; Xing, X.; Xiang, N.; Wu, Y.; Li, C.; Chen, Q.; Li, D.; Liu, T.; Zhao, J.; Liu, M.; Tu, W.; Chen, C.; Jin, L.; Yang, R.; Wang, Q.; Zhou, S.; Wang, R.; Liu, H.; Luo, Y.; Liu, Y.; Shao, G.; Li, H.; Tao, Z.; Yang, Y.; Deng, Z.; Liu, B.; Ma, Z.; Zhang, Y.; Shi, G.; Lam, T.T.Y.; Wu, J.T.K.; Gao, G.F.; Cowling, B.J.; Yang, B.; Leung, G.M.; Feng, Z. M and Feng Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med., 2020, 382(13), 1199-1207.
[http://dx.doi.org/10.1056/NEJMoa2001316] [PMID: 31995857]
[15]
Lee, P.I.; Hsueh, P.R. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J Microbiol Immunol Infect, 2020, 53(3), 365-7.
[http://dx.doi.org/10.1016/j.jmii.2020.02.001] [PMID: 32035811]
[16]
Zhang, W.; Du, R.H.; Li, B.; Zheng, X.S.; Yang, X.L.; Hu, B.; Wang, Y-Y.; Xiao, G-F.; Yan, B.; Shi, Z-L.; Zhou, P. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg. Microbes Infect., 2020, 9(1), 386-389.
[http://dx.doi.org/10.1080/22221751.2020.1729071] [PMID: 32065057]
[17]
Hamming, I.; Timens, W.; Bulthuis, M.L.; Lely, A.T.; Navis, G.; van Goor, H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol., 2004, 203(2), 631-637.
[http://dx.doi.org/10.1002/path.1570] [PMID: 15141377]
[18]
Jin, Y.H.; Cai, L.; Cheng, Z.S.; Cheng, H.; Deng, T.; Fan, Y.P.; Fang, C.; Huang, D.; Huang, L-Q.; Huang, Q.; Han, Y.; Hu, B.; Hu, F.; Li, B-H.; Li, Y-R.; Liang, K.; Lin, L-K.; Luo, L-S.; Ma, J.; Ma, L-L.; Peng, Z-Y.; Pan, Y-B.; Pan, Z-Y.; Ren, X-Q.; Sun, H-M.; Wang, Y.; Wang, Y-Y.; Weng, H.; Wei, C-J.; Wu, D-F.; Xia, J.; Xiong, Y.; Xu, H-B.; Yao, X-M.; Yuan, Y-F.; Ye, T-S.; Zhang, X-C.; Zhang, Y-W.; Zhang, Y-G.; Zhang, H-M.; Zhao, Y.; Zhao, M-J.; Zi, H.; Zeng, X-T.; Wang, Y-Y.; Wang, X-H. for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil. Med. Res., 2020, 7(1), 4.
[http://dx.doi.org/10.1186/s40779-020-0233-6] [PMID: 32029004]
[19]
Guan, W.J.; Ni, Z.Y.; Hu, Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med, 2020, 382, 1708-1720.
[http://dx.doi.org/10]
[20]
Wang, D.; Hu, B.; Hu, C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 2020, 3 23(11), 1061-9.
[http://dx.doi.org/10.1001/jama.2020.1585] [PMID: 32031570]
[21]
Poutanen, S.M.; Low, D.E.; Henry, B.; Finkelstein, S.; Rose, D.; Green, K.; Tellier, R.; Draker, R.; Adachi, D.; Ayers, M.; Chan, A.K.; Skowronski, D.M.; Salit, I.; Simor, A.E.; Slutsky, A.S.; Doyle, P.W.; Krajden, M.; Petric, M.; Brunham, R.C.; McGeer, A.J. microbiology laboratory, Canada; Canadian severe acute respiratory syndrome study team. Identification of severe acute respiratory syndrome in Canada. N Engl J Med, 2003, 348(20), 1995-2005.
[http://dx.doi.org/10.1056/NEJMoa030634] [PMID: 12671061]
[22]
Tian, S.; Hu, N.; Lou, J.; Chen, K.; Kang, X.; Xiang, Z.; Chen, H.; Wang, D.; Liu, N.; Liu, D.; Chen, G.; Zhang, Y.; Li, D.; Li, J.; Lian, H.; Niu, S.; Zhang, L.; Zhang, J. Characteristics of COVID-19 infection in Beijing. J. Infect., 2020, 80(4), 401-406.
[http://dx.doi.org/10.1016/j.jinf.2020.02.018] [PMID: 32112886]
[23]
Pasquier, B. Autophagy inhibitors. Cell. Mol. Life Sci., 2016, 73(5), 985-1001.
[http://dx.doi.org/10.1007/s00018-015-2104-y] [PMID: 26658914]
[24]
Slater, AF Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum Pharmacology and Therapeutics 57.2-3 , 1993, 203-235.
[http://dx.doi.org/10.1016/0163-7258(93)90056-J]
[25]
WHO. Coronavirus disease (COVID-2019) situation reports. 2020. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situationreports Accessed 5 Mar 2020.
[26]
Rothan, H.A.; Byrareddy, S.N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun, 2020, 109, 102433.
[http://dx.doi.org/10.1016/j.jaut.2020.102433] [PMID: 32113704]
[27]
Sun, P.; Lu, X.; Xu, C.; Sun, W.; Pan, B. Understanding of COVID-19 based on current evidence. J Med Virol, 2020, 92(6), 548-51.
[http://dx.doi.org/10.1002/jmv.25722] [PMID: 32096567]
[28]
Wang, W.; Tang, J.; Wei, F. Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China. J. Med. Virol., 2020, 92(4), 441-447.
[http://dx.doi.org/10.1002/jmv.25689] [PMID: 31994742]
[29]
Yang, X.; Yu, Y.; Xu, J.; Shu, H.; Xia, J.; Liu, H.; Wu, Y.; Zhang, L.; Yu, Z.; Fang, M.; Yu, T.; Wang, Y.; Pan, S.; Zou, X.; Yuan, S.; Shang, Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir. Med., 2020, 8(5), 475-481.
[http://dx.doi.org/10.1016/S2213-2600(20)30079-5]
[30]
Gao, H.N.; Lu, H.Z.; Cao, B.; Du, B.; Shang, H.; Gan, J.H.; Lu, S.H.; Yang, Y.D.; Fang, Q.; Shen, Y.Z.; Xi, X.M.; Gu, Q.; Zhou, X.M.; Qu, H.P.; Yan, Z.; Li, F.M.; Zhao, W.; Gao, Z.C.; Wang, G.F.; Ruan, L.X.; Wang, W.H.; Ye, J.; Cao, H.F.; Li, X.W.; Zhang, W.H.; Fang, X.C.; He, J.; Liang, W.F.; Xie, J.; Zeng, M.; Wu, X.Z.; Li, J.; Xia, Q.; Jin, Z.C.; Chen, Q.; Tang, C.; Zhang, Z.Y.; Hou, B.M.; Feng, Z.X.; Sheng, J.F.; Zhong, N.S.; Li, L.J. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N. Engl. J. Med., 2013, 368(24), 2277-2285.
[http://dx.doi.org/10.1056/NEJMoa1305584] [PMID: 23697469]
[31]
Wang, J.; Qi, H.; Bao, L.; Li, F.; Shi, Y. National Clinical Research Center for Child Health and Disorders and Pediatric Committee of Medical Association of Chinese People’s Liberation Army. A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units. Lancet Child Adolesc Health, 2020, 4(4), 258-9.
[http://dx.doi.org/10.1016/S2352-4642(20)30040-7] [PMID: 32043976]
[32]
Bonilla-Aldana, D.K.; Suárez, J.A.; Franco-Paredes, C.; Vilcarromero, S.; Mattar, S.; Gómez-Marín, J.E.; Villamil-Gómez, W.E.; Ruíz-Sáenz, J.; Cardona-Ospina, J.A.; Idarraga-Bedoya, S.E.; García-Bustos, J.J.; Jimenez-Posada, E.V.; Rodríguez-Morales, A.J. Brazil burning! What is the potential impact of the Amazon wildfires on vector-borne and zoonotic emerging diseases? - A statement from an international experts meeting. Travel Med. Infect. Dis., 2019, 31, 101474.
[http://dx.doi.org/10.1016/j.tmaid.2019.101474] [PMID: 31494225]
[33]
Ellwanger, J.H.; Chies, J.A.B. Zoonotic spillover and emerging viral diseases - time to intensify zoonoses surveillance in Brazil. Braz. J. Infect. Dis., 2018, 22(1), 76-78.
[http://dx.doi.org/10.1016/j.bjid.2017.11.003] [PMID: 29305828]
[34]
World Health Organization. Novel Coronavirus (2019-nCoV) - Situation report - 48 - 8 March 2020. Available from: https://www.who.int/emergencies/diseases/novelcoronavirus-2019/situation-reports/
[35]
CDC. 2019 Novel Coronavirus - Prevention & Treatment. Available from: https://www.cdc.gov/coronavirus/2019ncov/about/prevention-treatment.html
[36]
CDC U. 2019 Novel Coronavirus - Information for Healthcare Professionals, 2020. Available from: https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html
[37]
World Health Organization. Communicating risk in public health emergencies: a WHO guideline for emergency risk communication (ERC) policy and practice 2017. Available from: https://www.who.int/risk-communication/guidance/download/en/ 2017
[38]
World Health Organization. Statement on the meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available from: https://www.who.int/newsroom/detail/23-01-2020-statement-on-the-meetingof-the-international-health-regulations-(2005)emergency-committee-regarding-the-outbreak-ofnovel-coronavirus-(2019-ncov)
[39]
World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV). Available from: https://www.who. int/news-room/detail/30-01-2020-statement-onthe-second-meeting-of-the-international-healthregulations-(2005)-emergency-committee-regardingthe-outbreak-of-novel-coronavirus-(2019-ncov).
[40]
World Health Organization., Novel Coronavirus (2019-nCoV) - Situation report - 10 - 30 January 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200130-sitrep-10ncov.pdf?sfvrsn=d0b2e480_2
[41]
World Health Organization; List of Blueprint priority diseases, 2018. Available from: www.who.int/blueprint/priority-diseases/en/
[42]
Su, S; Wong, G; Shi, W; Liu, J; Lai, ACK; Zhou, J; Liu, W; Bi, Y; Gao, GF Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol, 2016, 24(6), 490-502.
[43]
Thompson, RN. Novel Coronavirus Outbreak in Wuhan, China, 2020: Intense surveillance is vital for preventing sustained transmission in new locations. J Clin Med, 2020, 9(2), E498.
[http://dx.doi.org/10.3390/jcm9020498] [PMID: 32054124]
[44]
Wong, A.C.P.; Li, X.; Lau, S.K.P.; Woo, P.C.Y. Global Epidemiology of Bat Coronaviruses. Viruses, 2019, 11(2), E174.
[http://dx.doi.org/10.3390/v11020174] [PMID: 30791586]
[45]
Cheng, AC; Williamson, DA An outbreak of COVID-19 caused by a new coronavirus: what we know so far. Med J Aust, 2020, 212(9), 393-4. e1.
[http://dx.doi.org/10.5694/mja2.50530] [PMID: 32146721]
[46]
Chen, L.; Liu, H.G.; Liu, W.; Liu, J.; Liu, K.; Shang, J.; Deng, Y.; Wei, S. [Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia Zhonghua Jie He He Hu Xi Za Zhi, 2020, 43(0), E005.
[PMID: 32026671]
[47]
Palacios Cruz, M; Santos, E; Velázquez Cervantes, MA; León Juárez, M COVID-19, a Worldwide Public Health Emergency. Rev Clin Esp., 2020, S0014-565(20)30092-8.
[48]
Chen, W.; Yan, M.; Yang, L.; Ding, B.; He, B.; Wang, Y.; Liu, X.; Liu, C.; Zhu, H.; You, B.; Huang, S.; Zhang, J.; Mu, F.; Xiang, Z.; Feng, X.; Wen, J.; Fang, J.; Yu, J.; Yang, H.; Wang, J. SARS-associated coronavirus transmitted from human to pig. Emerg. Infect. Dis., 2005, 11(3), 446-448.
[http://dx.doi.org/10.3201/eid1103.040824] [PMID: 15757562]
[49]
Chen, Y.; Liu, Q.; Guo, D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J. Med. Virol., 2020, 92(4), 418-423.
[http://dx.doi.org/10.1002/jmv.25681] [PMID: 31967327]
[50]
Cheng, V.C.C.; Wong, S.C.; To, K.K.W.; Ho, P.L.; Yuen, K.Y. Preparedness and proactive infection control measures against the emerging novel coronavirus in China. J. Hosp. Infect., 2020, 104(3), 254-255.
[http://dx.doi.org/10.1016/j.jhin.2020.01.010] [PMID: 31962139]
[51]
Hellewell, J.; Abbott, S.; Gimma, A.; Bosse, N.I.; Jarvis, C.I.; Russell, T.W.; Munday, J.D.; Kucharski, A.J.; Edmunds, W.J.; Funk, S.; Eggo, R.M. Centre for the Mathematical Modelling of Infectious Diseases COVID-19 Working Group. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob. Health, 2020, 8(4), e488-e496.
[http://dx.doi.org/10.1016/S2214-109X(20)30074-7] [PMID: 32119825]
[52]
Kaplan, E.H. Containing 2019-nCoV (Wuhan) coronavirus. Health Care Manage Sci, 2020, 23(3), 311-4.
[http://dx.doi.org/10.1007/s10729-020-09504-6] [PMID: 32146554]
[53]
Shen, K; Yang, Y; Wang, T Diagnosis, treatment, and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement. World J Pediatr, 2020, 16(3), 223-31.
[http://dx.doi.org/10.1007/s12519-020-00344-6] [PMID: 32026147]